Prof Amminger is a Psychiatrist, Head of Neuroprotective Biotherapies Research at Orygen, and Professor of Neurobiology and Neuroprotection in Emerging Mental Disorders at the Centre of Youth Mental Health, University of Melbourne. He pioneered the use of omega-3 fatty acids for preventing psychosis in young people at high risk, providing an avenue for early intervention. He is engaged in clinical trials research testing agents with favourable risk-benefit ratio for treatment and preventive use in young people with mental health problems.
Professor Paul Amminger
9 November 2021Related Posts
CREDIT Researchers feature in Magda’s Big National Health Check
Professor Pat McGorry (Orygen) and Alfred Deakin Professor Felice Jacka
Continue Reading
Current research into new treatments for bipolar depression
A team including CREDIT CRE researchers have recently published a
Continue Reading
Impact of ultra-processed foods on the brain
Listen to the fascinating conversation that Alfred Deakin Professor Felice
Continue Reading
IMPACT researchers named on Highly Cited Researchers list
Nine Deakin University academics have been named among the world’s most influential researchers in their fields following the release of the 2023 Clarivate™ Highly Cited Researchers™ list. Four of the members are researchers at IMPACT. A Highly Cited Researcher is an individual who has demonstrated significant and broad influence in their field(s) of research. Each […]
Continue Reading